Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
42%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
IHE
36
HOLDINGS
43%
ALSO IN FTXH
FTXH
49
HOLDINGS
31%
ALSO IN IHE
SECTOR DRIFT (IHE minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 25.5% | 8.3% | 8.3% |
|
MERCK & CO. INC. | 4.6% | 6.9% | 4.6% |
|
PFIZER INC | 4.6% | 7.3% | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.2% | 6.1% | 4.2% |
|
VIATRIS, INC. | 4.9% | 4.1% | 4.1% |
IHE Overweight Relative to FTXH
|
JOHNSON & JOHNSON | 17.2% |
|
ELI LILLY & CO | 15.0% |
|
ROYALTY PHARMA PLC CLASS A | 5.0% |
|
CORCEPT THERAPEUTICS INC | 2.8% |
|
AXSOME THERAPEUTICS, INC. | 1.7% |
|
LIGAND PHARMACEUTICALS-CL B | 1.4% |
|
ELANCO ANIMAL HEALTH, INC. | 1.4% |
|
SUPERNUS PHARMACEUTICALS INC | 1.2% |
|
PRESTIGE BRANDS HOLDINGS INC | 1.0% |
|
TARSUS PHARMACEUTICALS, INC. | 0.9% |
IHE Underweight Relative to FTXH
|
ABBVIE INC | -7.5% |
|
GILEAD SCIENCES INC | -4.1% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
AMGEN INC | -3.7% |
|
BIOGEN IDEC INC | -3.7% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
PFIZER INC | -2.7% |
|
MEDPACE HOLDINGS, INC. | -2.6% |
|
MERCK & CO. INC. | -2.3% |
|
CHARLES RIVER LABORATORIES | -2.0% |